In situ melanin assay for MSH using mouse B16 melanoma cells in culture
โ Scribed by Walter Siegrist; Alex N. Eberle
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 521 KB
- Volume
- 159
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
โฆ Synopsis
A sensitive in situ melanin assay using cultured mouse B16 melanoma cells is described for structure-activity studies with melanocyte-stimulating hormone (MSH) peptides. B16 Cells were seeded at a density of 2500 cells per well in 96-well microtest tissue culture plates; aher 24 h the cells were incubated in the presence of serial dilutions of MSH peptides for 3 to 5 days. The melanin released into the medium of each well was then determined spectrophotometrically at a wavelength of 405 nm using an automatic microplate reader calibrated against synthetic melanin. Studies with (u-MSH, [Nle4, D-Phe']-a-MSH, [3'-iodo-Ty?]-ol-MSH, adrenocorticotropin (ACTH)( l-24), and ACTH( l-39) showed that the peptides had identical intrinsic activities and that the relative potencies were similar to those obtained with a tyrosinase assay. The EC50 of OI-MSH was 27 PM, i.e., about five-to sevenfold lower than that in the assays for tyrosinase or intracellular melanin. Thus, the new assay represents the most sensitive melanoma cell assay for MSH available to date. o 1986 Academic PKSS, tnc.
๐ SIMILAR VOLUMES
The effect of theophylline, an inhibitor of phosphodiesterase, on tyrosine (Tyr) transport across cell membrane was studied using cultured B-16 mouse melanoma cells. 1.5 mM Theophylline in culture medium increased Tyr uptake velocity in linear fashion up to 36 h, after which it reached a plateau at
Prostaglandin D 2 (PGD2) is lethal to murine and human melanoma cells at high doses, but synchronizes cells at G 1 at non-toxic doses (2.5 or 5/xg/ml). We tested the lethality to B16 mouse melanoma cells of combinations of PGD 2 with anticancer drugs. The drugs selected were mostly those used in tre
Gelsolin, an actin-binding protein, is implicated as a critical regulator in cell motility. In addition, we have reported that cellular levels of gelsolin are decreased in various tumor cells, and overexpression of gelsolin by gene transfer suppresses tumorigenicity. We sought to assess the effects